EXPLAINED: Is davita stock underperforming the s p 500 | Rare Historical Photos

Headquartered in Denver, Colorado, DaVita Inc. (DVA) provides kidney dialysis services for patients suffering from chronic kidney failure. Valued at $10.3 billion by market cap, the company operates kidney dialysis centers and provides related lab services in outpatient dialysis centers. 

Companies worth $10 billion or more are generally described as “large-cap stocks,” and DVA perfectly fits that description, with its market cap exceeding this mark, underscoring its size, influence, and dominance within the medical care facilities industry. Its scale, operating over 3,000 dialysis centers nationwide, enables cost efficiencies, strong brand recognition, and a vast clinical network. DaVita benefits from long-term relationships with nephrologists and payors, including value-based care arrangements with Medicare and commercial insurers, which help stabilize revenue.